James E. Audia

James E. Audia

Director/Miembro de la Junta en
Ribon Therapeutics, Inc.
.
70 años
Health Technology
Consumer Services
Commercial Services

Perfil

James E.
Audia
is currently the Director at Ribon Therapeutics, Inc. and a Member at Alzheimer's Association.
Previously, he served as the Independent Director at Constellation Pharmaceuticals, Inc. from 2011 to 2021.
He was also the Executive Director at Chicago Biomedical Consortium from 2017 to 2019.
Additionally, he held the position of Head-Chemistry at Karuna Therapeutics, Inc. from 2019 to 2024.
Dr. Audia obtained his doctorate degree from Yale University and the University of South Carolina.

Cargos activos de James E. Audia

EmpresasCargoInicio
Director/Miembro de la Junta 01/04/2018
Corporate Officer/Principal 01/01/2020

Antiguos cargos conocidos de James E. Audia.

EmpresasCargoFin
KARA THER Corporate Officer/Principal 18/03/2024
CONSTELLATION PHARMACEUTICALS, INC. Director Técnico/Científico/I+D 01/07/2017
Chicago Biomedical Consortium
Director/Miembro de la Junta 01/10/2019
Ver el detalle de la experiencia de James E. Audia.

Formación de James E. Audia.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

54

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Chicago Biomedical Consortium